日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Continuity of long-term follow-up in patients with chronic hepatitis C after sustained virologic response following direct-acting antiviral therapy: a nationwide real-world multicenter cohort study in Japan

日本一项全国性真实世界多中心队列研究:慢性丙型肝炎患者接受直接抗病毒治疗后获得持续病毒学应答后长期随访的连续性

Ohara, Masatsugu; Kozuka, Ritsuzo; Uchida, Yoshihito; Iino, Chikara; Sasaki, Ryo; Tojima, Hiroki; Kawata, Kazuhito; Kakizaki, Satoru; Tokumoto, Yoshio; Endo, Mizuki; Asai, Akira; Inoue, Jun; Nagata, Kenji; Takahashi, Hirokazu; Shimakami, Tetsuro; Ogawa, Koji; Enomoto, Masaru; Ikegami, Tadashi; Ide, Tatsuya; Sakamoto, Naoya; Korenaga, Masaaki

Primary Hepatic Squamous Cell Carcinoma

原发性肝鳞状细胞癌

Kim, Soo Ryang; Kim, Soo Ki; Kobayashi, Hisato; Okuda, Toyokazu; Fujii, Yumi; Sakamoto, Makiho; Koma, Yu-Ichiro; Nakashima, Osamu; Sasaki, Motoko; Asai, Akira; Nishikawa, Hiroki

Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Review of Literature

代谢功能障碍相关脂肪肝和肌少症:文献综述

Nishikawa, Hiroki; Kim, Soo Ki; Yoshio, Sachiyo; Asai, Akira

Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II-Associated Non-Islet Cell Tumor Hypoglycemia

循环microRNA-483作为IGF-II相关非胰岛细胞肿瘤低血糖症生物标志物的潜在应用价值

Okazaki-Hada, Mikiko; Nagao, Mototsugu; Asai, Akira; Okada-Iwabu, Miki; Hizuka, Naomi; Eliasson, Lena; Sugihara, Hitoshi; Fukuda, Izumi; Iwabu, Masato

Impact of Alcohol Intake on Body Composition in Patients with Steatotic Liver Disease

酒精摄入对脂肪肝患者身体成分的影响

Matsui, Masahiro; Fukuda, Akira; Onishi, Saori; Ushiro, Kosuke; Nishikawa, Tomohiro; Asai, Akira; Kim, Soo Ki; Nishikawa, Hiroki

Impact of Alcohol Intake on Skeletal Muscle: A Large Cross-Sectional Analysis in Japanese Adults

酒精摄入对骨骼肌的影响:一项针对日本成年人的大型横断面分析

Matsui, Masahiro; Fukuda, Akira; Onishi, Saori; Ushiro, Kosuke; Nishikawa, Tomohiro; Asai, Akira; Kim, Soo Ki; Nishikawa, Hiroki

The Role of Myokines in Liver Diseases

肌细胞因子在肝脏疾病中的作用

Nishikawa, Hiroki; Kim, Soo Ki; Asai, Akira

Network-based insights into miRNA regulation of β-cell insulin secretion in type 2 diabetes.

基于网络的miRNA调控2型糖尿病β细胞胰岛素分泌的研究进展。

Cowan Elaine, Karagiannopoulos Alexandros, Pollastri Alessio, Asai Akira, Nagao Mototsugu, Maziarz Marlena, Esguerra Jonathan L S, Eliasson Lena

Pharmacophore-Based Structure Optimization of S‑Trityl‑l‑Cysteine Derivatives for Cytotoxic Payload Applications

基于药效团的S-三苯甲基-L-半胱氨酸衍生物结构优化及其在细胞毒性有效载荷应用中的应用

Ichida, Taiki; Ogo, Naohisa; Murase, Keisuke; Fukai, Ryota; Sawada, Jun-Ichi; Murakami, Hisashi; Asai, Akira

Rebastinib inhibits FoxO1 activity and reduces dexamethasone-induced atrophy and its-related gene expression in cultured myotubes.

瑞巴替尼抑制 FoxO1 活性,减少地塞米松诱导的肌管萎缩及其相关基因表达

Sato Tomoki, Morita Akihito, Watanabe Yui, Naito Yumi, Kawaji Haruka, Nakagawa Takumi, Hamaguchi Hiroki, Manabe Yasuko, Fujii Nobuharu L, Ogo Naohisa, Asai Akira, Kamei Yasutomi, Miura Shinji